AllianceBernstein’s Viela Bio, Inc. Common Stock VIE Stock Holding History

AllianceBernstein’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-32,900	Closed	-$1.18M	–	3351
2020 Q4	$1.18M	Sell	32,900 -31,876	-49%	-$1.12M	﹤0.01%	2226
2020 Q3	$1.82M	Buy	64,776 +2,198	+4%	+$77.8K	﹤0.01%	1904
2020 Q2	$2.71M	Buy	62,578 +11,759	+23%	+$532K	﹤0.01%	1670
2020 Q1	$1.93M	Sell	50,819 -39,934	-44%	-$1.56M	﹤0.01%	1685
2019 Q4	$2.46M	Buy	+90,753	New	+$2.29M	﹤0.01%	1847

AllianceBernstein's VIE Position: Q1 2021 in Review

AllianceBernstein sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 32,900 shares — an estimated $1.18M sold.

AllianceBernstein first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $2.71M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

AllianceBernstein reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
AllianceBernstein sold 32,900 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $1.18M.
AllianceBernstein first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
AllianceBernstein's Viela Bio, Inc. Common Stock position peaked at $2.71M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on AllianceBernstein's 13F filing for Q1 2021, filed 6 May 2021.